Cleared Traditional

FLEXLAB 3.6, ACCELERATOR A3600 (K121012) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K121012 · Inpeco S.P.A. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
150d
Days
Class 2
Risk

K121012 is an FDA 510(k) clearance for the FLEXLAB 3.6, ACCELERATOR A3600. Classified as Electrode, Ion Specific, Potassium (product code CEM), Class II - Special Controls.

Submitted by Inpeco S.P.A. (Segrate, Milan, IT). The FDA issued a Cleared decision on August 31, 2012 after a review of 150 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1600 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Inpeco S.P.A. devices

Submission Details

510(k) Number K121012 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2012
Decision Date August 31, 2012
Days to Decision 150 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 88d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEM Electrode, Ion Specific, Potassium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEM Electrode, Ion Specific, Potassium

All 88
Devices cleared under the same product code (CEM) and FDA review panel - the closest regulatory comparables to K121012.
ISE indirect K for Gen.2
K253491 · Roche Diagnostics · Feb 2026
ABL90 FLEX PLUS System
K241037 · Radiometer Medicals Aps · Jan 2025
EasyStat 300
K220396 · Medica Corporation · Sep 2023
ISE Electrodes
K230890 · Randox Laboratories, Ltd. · Sep 2023
SmartLyte® Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+
K200544 · Diamond Diagnostics, Inc. · Oct 2020
ACCELERATOR APS
K093318 · Abbott Laboratories · Feb 2010